Results 21 to 30 of about 9,107,562 (256)

Survival of 48866 cancer patients: results from Nantong area, China

open access: yesFrontiers in Oncology, 2023
ObjectiveThis study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China.MethodsPatients with cancer registered between 2007 and 2017 in the Nantong ...
Gao-Ren Wang   +11 more
doaj   +1 more source

Opportunities and Challenges of Surveillance for Liver Cancer in Primary Care Institutions in China [PDF]

open access: yesZhongguo quanke yixue, 2023
Primary liver cancer (PLC) is one of the common malignant tumors and the main causes of tumor death in China. Although the diagnosis and treatment technology of PLC in China has made great progress in recent years, its morbidity and mortality have been ...
WANG Shiyue, DONG Chen, CHANG Chudi, NAN Yuemin
doaj   +1 more source

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]

open access: yes, 2013
Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
Dhiraj Yadav   +15 more
core   +2 more sources

Molecular mechanisms of insulin resistance in chronic liver disease [PDF]

open access: yes, 2008
The work presented here analyses the role of PP2A in the dysregulation of glucose metabolism in the setting of chronic hepatitis C. We propose a new model for virus induced insulin resistance development through the overexpression of PP2A in the liver ...
Bernsmeier, Christine
core   +1 more source

Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]

open access: yes, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem   +23 more
core   +2 more sources

Clinical characteristics and homology analysis of Staphylococcus aureus from would infection at a tertiary hospital in southern Zhejiang, China

open access: yesBMC Microbiology, 2023
Objective Staphylococcus aureus (S. aureus), especially Methicillin resistant S. aureus (MRSA), has been disseminated across communities and hospitals, associated with severe infections and organ failure.
Jiarong Zhang   +3 more
doaj   +1 more source

Medication adherence in adolescents and young children with chronic liver disease [PDF]

open access: yes, 2022
Section A is a review of existing empirical research that has investigated variables associated with medication adherence in adolescents and young adults (9-25 years) with a chronic liver disease.
Fall, K.
core  

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B [PDF]

open access: yes, 2005
Background: HBV infection is a serious global heath problem. It is crucial to monitor this disease more closely with a non-invasive marker in clinical trials.
Montazeri, G.   +30 more
core   +2 more sources

Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases [PDF]

open access: yesZhongguo quanke yixue, 2023
The liver is the largest metabolic organ in the human body, and impaired liver function can lead to a variety of acute and chronic liver diseases, which can affect the quality of life in mild cases or be life-threatening in severe cases. Therefore, it is
YUAN Xiwei, NAN Yuemin
doaj   +1 more source

Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE) [PDF]

open access: yes, 2007
Liver function tests (LFTs) are routinely performed in primary care, and are often the gateway to further invasive and/or expensive investigations.
David McLernon   +38 more
core   +2 more sources

Home - About - Disclaimer - Privacy